AptarGroup Bets On Transformation Plan, Innovative Products
Zacks Investment Research | May 23, 2019 09:17PM ET
On May 23, we issued an updated research report on AptarGroup, Inc. (NYSE:ATR) . The company is poised to gain from its business-transformation plan, innovative product rollouts and acquisitions.
Let’s illustrate these factors in detail.
Business-Transformation Plan: A Key Growth Driver
In late 2017, AptarGroup began a business-transformation plan to drive the top line, boost operational excellence, enhance approach to innovation and improve organizational effectiveness. The company is on track with its business transformation which primarily focuses on the Beauty + Home segment. The company expects the business-transformation plan to yield incremental EBITDA of approximately $80 million by 2020-end.
Innovation Provides a Competitive Edge
AptarGroup is poised to gain from recent innovative product launches. In the Pharma segment, the Bidose Nasal Spray Device was recently approved by the U.S. FDA for breakthrough therapy in the field of depression. This vital system is a prime less, intuitive and easy to use device with 360-degree functionality and precise spray characteristic delivering two shots of medicine within the single device. This is the first FDA approval and U.S. launch of a prescription drug using AptarGroup’s patented Bidose Nasal Spray delivery system.
In the Beauty + Home segment, the company has Skin Care Dispensing Pen in China. It features a magnetic applicator which delivers active ingredients to each spot with three times the absorption rate than application with finger. In the Food + Beverage segment, the company has launched flip-lid closure with SimpliSqueeze Valve technology and a built-in tamper evident pull ring fitment for sauces and condiments.
Acquisitions to Grow Business
AptarGroup remains committed to business expansion through acquisitions to broaden the scope of technologies, geographic presence and product offerings. In sync with this, the company acquired CSP Technologies, a leader in active packaging technology based on proprietary material science expertise.
In May 2018, AptarGroup acquired 100% of the common stock of Reboul, a French manufacturer specializing in stamping, decorating and assembling metal and plastic packaging for the cosmetics and luxury markets. Moreover, the company has acquired several companies, including Stelmi, Mega Airless, and made a minority investment in Kali Care, Inc., over the past few years. Last year, it also expanded partnership with Propeller Health and made a strategic equity investment in the company. These acquisitions will drive growth.
Price Performance
AptarGroup’s shares have gained 20.1% over the past year, against the Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.